Medicare Enrolled

Dr. Krystle Wang, M.D.

Dermatology · Mountain View, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
2490 HOSPITAL DR, Mountain View, CA 94040
6509624600
In practice since 2010 (16 years)
NPI: 1386960847 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wang

Dr. Krystle Wang is a dermatology specialist in Mountain View, CA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Wang performed 1,831 Medicare services across 650 unique beneficiaries.

Between the years covered by Open Payments, Dr. Wang received a total of $30,018 from 45 pharmaceutical and/or device companies across 586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ 1,831 Medicare services $30,018 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,831
Medicare services
Bottom 42% in CA for dermatology
650
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~114 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
894 $7 $17
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
376 $80 $217
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
206 $58 $165
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
76 $115 $306
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
70 $119 $293
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
62 $1 $10
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
43 $14 $34
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
37 $97 $268
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
29 $64 $175
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
24 $95 $265
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
14 $35 $176
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$30,018
Total received (2018-2024)
Avg $4,288/year across 7 years
Top 8% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
586
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$18,004 (60.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,013 (40.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,135
2023
$2,509
2022
$1,680
2021
$1,207
2020
$1,095
2019
$1,096
2018
$19,296

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$643
Regeneron Healthcare Solutions, Inc.
$299
GENZYME CORPORATION
$250
Lilly USA, LLC
$232
Novartis Pharmaceuticals Corporation
$210
Janssen Biotech, Inc.
$180
UCB, Inc.
$180
Incyte Corporation
$169
Boehringer Ingelheim Pharmaceuticals, Inc.
$123
Galderma Laboratories, L.P.
$116
Dermavant Sciences, Inc.
$109
LEO Pharma Inc.
$87
E.R. Squibb & Sons, L.L.C.
$85
SUN PHARMACEUTICAL INDUSTRIES INC.
$84
Arcutis Biotherapeutics, Inc.
$68
Amgen Inc.
$62
REVANCE THERAPEUTICS, INC.
$53
STRATA Skin Sciences, Inc.
$49
Organogenesis Inc.
$44
Fresenius Kabi USA, LLC
$29
Ortho Dermatologics, a division of Bausch Health US, LLC
$25
MERZ NORTH AMERICA, INC.
$22
PFIZER INC.
$19
Top 3 companies account for 38.0% of 2024 payments
All-time payments by company (2018-2024) ›
Lumenis (Germany) GmbH
$9,174
Allergan Inc.
$4,678
Lumenis, Inc
$3,192
Regeneron Healthcare Solutions, Inc.
$1,461
ABBVIE INC.
$1,097
Solta Medical, a division of Bausch Health US, LLC
$1,024
Novartis Pharmaceuticals Corporation
$944
Lilly USA, LLC
$901
Janssen Biotech, Inc.
$869
AbbVie Inc.
$791
GENZYME CORPORATION
$747
Galderma Laboratories, L.P.
$563
UCB, Inc.
$523
PFIZER INC.
$451
LEO Pharma Inc.
$336
Sun Pharmaceutical Industries Inc.
$310
AbbVie, Inc.
$296
Incyte Corporation
$278
Ortho Dermatologics, a division of Bausch Health US, LLC
$259
E.R. Squibb & Sons, L.L.C.
$199
Dermavant Sciences, Inc.
$179
MAYNE PHARMA INC.
$172
Arcutis Biotherapeutics, Inc.
$162
Boehringer Ingelheim Pharmaceuticals, Inc.
$152
Almirall LLC
$141
Amgen Inc.
$139
Celgene Corporation
$109
SUN PHARMACEUTICAL INDUSTRIES INC.
$108
Genentech USA, Inc.
$93
Aclaris Therapeutics, Inc.
$88
Mayne Pharma Inc.
$73
Journey Medical Corporation
$65
Fresenius Kabi USA, LLC
$60
REVANCE THERAPEUTICS, INC.
$53
STRATA Skin Sciences, Inc.
$49
Allergan, Inc.
$47
Organogenesis Inc.
$44
ORGANOGENESIS INC.
$39
DERMIRA, INC.
$34
SANOFI-AVENTIS U.S. LLC
$27
Biofrontera Inc.
$22
MERZ NORTH AMERICA, INC.
$22
VYNE Pharmaceuticals Inc.
$20
Merck Sharp & Dohme Corporation
$14
EPI Health, LLC
$12
Top 3 companies account for 56.8% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Aczone · BOTOX · BOTOX COSMETIC · Bimzelx · CIBINQO · COSENTYX · CYLTEZO · Cabtreo · Cimzia · DAXI · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · ESKATA · EUCRISA · Enbrel · Erivedge · Exelderm · HUMIRA · Humira · IDACIO · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · JUBLIA · ONEXTON · OPZELURA · Otezla · PURAPLY AM · Puraply Antimicrobial · QBREXZA · REMICADE · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Sitavig · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA · Winlevi · XOLAIR · XTRAC · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (60%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in dermatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for dermatology in CA.

Looking for a dermatology specialist in Mountain View?
Compare dermatologists in the Mountain View area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
265
Per 100K population
13.9
County median income
$159,674
Nearest hospital
EL CAMINO HEALTH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wang is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 8% of CA peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wang experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Wang performed 894 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wang receive payments from pharmaceutical companies?
Yes. Dr. Wang received a total of $30,018 from 45 companies across 586 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wang's costs compare to other dermatologists in Mountain View?
Dr. Wang's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →